Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Proxima Ventures is a Shanghai-based venture capital firm established to invest in the healthcare sector. Founded with the mission to support entrepreneurs, Proxima Ventures focuses on innovative solutions across medical devices, biotechnology, pharmaceuticals, diagnostics, and healthcare services. The firm operates from key locations in Shanghai, Beijing, and Hong Kong, allowing it to tap into a diverse range of opportunities within the healthcare market.
Currently, Proxima Ventures manages a portfolio that includes several notable companies in the healthcare space. The firm is recognized for its commitment to advancing next-generation healthcare technologies that can lead to significant improvements in public health. Proxima Ventures has built a reputation for connecting scientific breakthroughs with clinical applications, ensuring that innovations effectively address unmet healthcare needs.
As of now, Proxima Ventures has a growing team of professionals dedicated to identifying and supporting healthcare entrepreneurs. The firm actively seeks partnerships with startups that have the potential to disrupt traditional healthcare delivery and outcomes. This focus on healthcare innovation positions Proxima Ventures as a key player in the global venture capital landscape.
Proxima Ventures primarily invests in the healthcare sector, with a strong emphasis on sub-sectors such as medical devices, biotechnology, pharmaceuticals, diagnostics, and healthcare services. The firm targets various stages of investment, including angel, seed, Series A, and growth equity, allowing it to engage with startups at different points in their development.
Investment interests include areas addressing cardiovascular, digestive, respiratory, ophthalmology, oncology, autoimmune diseases, metabolic diseases, and central nervous system disorders. Proxima Ventures looks for entrepreneurs who are developing innovative technologies that can significantly improve public health outcomes. The firm values scientific and engineering breakthroughs that can translate into clinical applications, ensuring that their investments align with pressing healthcare needs.
Geographically, Proxima Ventures has a global focus, with particular attention to opportunities in Asia. The firm is well-positioned to leverage its extensive network within the healthcare ecosystem, including partnerships with industry leaders and hospitals, to enhance the growth potential of its portfolio companies.
Proxima Ventures has invested in a diverse range of companies within the healthcare sector, showcasing its commitment to supporting innovative solutions. Notable portfolio companies include:
This portfolio reflects Proxima Ventures' strategic focus on healthcare innovations that have the potential to transform patient care and improve health outcomes.
Luke Sun - Managing Partner: Luke has extensive experience in biotech and medical-device investing. He is recognized for his role in founding Proxima Ventures and has been instrumental in shaping its investment strategy.
George Li - Managing Partner: George focuses on medical devices and diagnostics. He has a background in founding Biohub and co-founding Bioherms, with significant experience in incubating and investing in life-science companies.
Haolin Sung - Partner: Haolin specializes in early and mid-stage healthcare and biotech investments. He has contributed to building companies like VerImmune and DotBio, and he serves on DotBio’s board after its Pre-Series A.
Cathy Zhang - Partner: Cathy brings expertise in healthcare investments and has a strong track record in supporting portfolio companies through their growth phases.
Elaine Niu - Partner: Elaine is involved in strategic decision-making and has a background in healthcare investment, contributing to Proxima's overall vision.
Junjie Yang, PhD - Venture Partner: Junjie has a strong academic background and experience in biotech, providing valuable insights into scientific advancements.
Bin Shi, PhD - Venture Partner: Bin's expertise in life sciences enhances Proxima's ability to evaluate and support innovative healthcare startups.
Ben Wang - Managing Director: Ben plays a key role in managing investments and guiding portfolio companies towards successful outcomes.
Bailey Zhu - Managing Director: Bailey focuses on operational support for portfolio companies, ensuring they have the resources needed to scale.
Steven Wang - Senior Director: Steven is involved in strategic planning and investment analysis, contributing to Proxima's investment decisions.
Yuqin Zhang, M.D. - Associate Director: Yuqin provides clinical insights and supports the evaluation of healthcare technologies.
Sophia Li - Associate Director: Sophia focuses on market analysis and helps identify promising investment opportunities.
Ying Zhang - Senior Associate: Ying supports due diligence and portfolio management activities.
Kun Peng, PhD - Senior Associate: Kun's scientific expertise aids in assessing the viability of healthcare innovations.
Karen Zeng - Investment Analyst: Karen conducts market research and analysis to support investment decisions.
Shirley Wu - Financial Director: Shirley oversees financial operations and ensures the firm's fiscal health.
Gary Lan - Senior Legal Director: Gary manages legal matters related to investments and compliance.
Echo Wang - Senior HR Director: Echo is responsible for talent acquisition and organizational development.
Benita Zhao - IR Manager: Benita handles investor relations and communication strategies.
Nissa - Operation Manager: Nissa oversees operational processes within the firm.
To pitch Proxima Ventures, founders should send an email to bp@proximavc.com. It is recommended to include a comprehensive pitch deck that outlines the startup's vision, market opportunity, and how the technology addresses specific healthcare challenges. While there is no formal application process disclosed, a well-structured pitch can significantly enhance the chances of engagement.
Response times may vary, but founders should expect a thorough review process given the firm's focus on healthcare innovations. A warm introduction can be beneficial, especially if it comes from a trusted source within the healthcare ecosystem.
In October 2025, Proxima Ventures participated in BridGene Biosciences' Series B+ funding round, contributing to a total of $28 million raised for the biotechnology company.
In September 2025, Proxima Ventures was involved in Rapafusyn Pharmaceuticals' Series A financing, which raised $44 million to advance its non-degrading molecular glue therapeutics.
Earlier in January 2025, Proxima Ventures participated in equity financing for TrendTec New Materials, securing several million USD to support the development of medical-grade ceramic materials.
In August 2023, Proxima Ventures co-led DotBio's Pre-Series A round, raising $5.6 million for the development of multi-functional and intracellular antibody therapies.
What are Proxima Ventures' investment criteria?
Proxima Ventures focuses on the healthcare sector, investing in medical devices, biotechnology, pharmaceuticals, diagnostics, and healthcare services. They target companies addressing significant healthcare challenges, particularly in areas like oncology, cardiovascular, and autoimmune diseases.
How can I pitch to Proxima Ventures?
Founders can reach out to Proxima Ventures via email at bp@proximavc.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and how the technology addresses unmet healthcare needs.
What makes Proxima Ventures different from other VCs?
Proxima Ventures distinguishes itself through its exclusive focus on healthcare innovations and its extensive network within the healthcare ecosystem, which includes partnerships with hospitals and industry leaders. This enables them to provide not just capital, but also strategic guidance and connections to their portfolio companies.
What is the geographic focus of Proxima Ventures?
Proxima Ventures has a global investment strategy, with a particular emphasis on opportunities in Asia. They are also open to cross-border investments, especially in the U.S. and Singapore.
What is the typical check size for investments?
While specific check sizes are not disclosed, Proxima Ventures invests across various stages, from angel to growth equity, indicating a flexible approach to funding based on the needs of the startup.
What kind of support do portfolio companies receive?
Proxima Ventures provides operational support, strategic guidance, and access to their extensive network within the healthcare sector, helping portfolio companies to scale effectively and address market needs.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.